As of 2025-02-09, the EV/EBITDA ratio of Marinus Pharmaceuticals Inc (MRNS) is -0.36. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRNS's latest enterprise value is 43.33 mil USD. MRNS's TTM EBITDA according to its financial statements is -121.83 mil USD. Dividing these 2 quantities gives us the above MRNS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
Range | Selected | |
Trailing P/E multiples | 7.6x - 8.7x | 8.2x |
Forward P/E multiples | 7.2x - 14.2x | 10.1x |
Fair Price | (17.01) - (19.48) | (20.43) |
Upside | -3195.9% - -3645.8% | -3818.5% |
Date | EV/EBITDA |
2025-02-07 | -0.36 |
2025-02-06 | -0.36 |
2025-02-05 | -0.36 |
2025-02-04 | -0.35 |
2025-02-03 | -0.35 |
2025-01-31 | -0.35 |
2025-01-30 | -0.35 |
2025-01-29 | -0.35 |
2025-01-28 | -0.35 |
2025-01-27 | -0.35 |
2025-01-24 | -0.35 |
2025-01-23 | -0.35 |
2025-01-22 | -0.35 |
2025-01-21 | -0.35 |
2025-01-17 | -0.35 |
2025-01-16 | -0.35 |
2025-01-15 | -0.35 |
2025-01-14 | -0.35 |
2025-01-13 | -0.35 |
2025-01-10 | -0.35 |
2025-01-08 | -0.35 |
2025-01-07 | -0.35 |
2025-01-06 | -0.35 |
2025-01-03 | -0.35 |
2025-01-02 | -0.35 |
2024-12-31 | -0.35 |
2024-12-30 | -0.35 |
2024-12-27 | -0.27 |
2024-12-26 | -0.25 |
2024-12-24 | -0.22 |
2024-12-23 | -0.21 |
2024-12-20 | -0.21 |
2024-12-19 | -0.21 |
2024-12-18 | -0.22 |
2024-12-17 | -0.22 |
2024-12-16 | -0.22 |
2024-12-13 | -0.23 |
2024-12-12 | -0.23 |
2024-12-11 | -0.24 |
2024-12-10 | -0.23 |
2024-12-09 | -0.24 |
2024-12-06 | -0.24 |
2024-12-05 | -0.23 |
2024-12-04 | -0.24 |
2024-12-03 | -0.25 |
2024-12-02 | -0.26 |
2024-11-29 | -0.25 |
2024-11-27 | -0.25 |
2024-11-26 | -0.25 |
2024-11-25 | -0.25 |